By rray, 15 March, 2023 Note Activity of anti SARS CoV 2 specific monoclonal antibodies against currently circulating variants is significantly reduced tx w these agents is NOT recommended
By rray, 15 March, 2023 Insufficient evidence for or against any antiviral tx consider tx based on age other risk factors